Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

B. Riley analyst, Eric Wold, reiterated his Buy rating on shares of IMAX Corporation (NYSE: IMAX) but cut estimates with two-thirds of Q4 in the books and a tough comp on the horizon.

The analyst cut his IMAX Corporation (IMAX) Q4 box office projection after a few disappointments and a more conservative stance for December (which flows into overall estimate reductions for 2016-2018).

The analyst believes the 2016 film slate is not IMAX-friendly and there has been a continued risk to box office projections throughout the year. For investors that can look past short-term slate misses, he believes the outlook for 2017/2018 remains impressive (and increasingly 2018 is a likely firm date for Avatar 2) which should drive attractive margin/cash flow expansion for IMAX.

No change to Buy rating but the PT of $41.50 is down from $42.50 on an unchanged multiple on reduced EBITDA estimates.

For an analyst ratings summary and ratings history on IMAX Corporation click here. For more ratings news on IMAX Corporation click here.